Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vascular progenitors: from biology to treatment.
Luttun A, Carmeliet G, Carmeliet P. Luttun A, et al. Among authors: carmeliet g, carmeliet p. Trends Cardiovasc Med. 2002 Feb;12(2):88-96. doi: 10.1016/s1050-1738(01)00152-9. Trends Cardiovasc Med. 2002. PMID: 11852257 Review.
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nübe O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P. Heymans S, et al. Among authors: carmeliet p. Nat Med. 1999 Oct;5(10):1135-42. doi: 10.1038/13459. Nat Med. 1999. PMID: 10502816
Molecular mechanisms of blood vessel growth.
Conway EM, Collen D, Carmeliet P. Conway EM, et al. Among authors: carmeliet p. Cardiovasc Res. 2001 Feb 16;49(3):507-21. doi: 10.1016/s0008-6363(00)00281-9. Cardiovasc Res. 2001. PMID: 11166264 Review.
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noël A. Bajou K, et al. Among authors: carmeliet g, carmeliet p. J Cell Biol. 2001 Feb 19;152(4):777-84. doi: 10.1083/jcb.152.4.777. J Cell Biol. 2001. PMID: 11266468 Free PMC article.
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Carmeliet P, et al. Nat Med. 2001 May;7(5):575-83. doi: 10.1038/87904. Nat Med. 2001. PMID: 11329059 Free article.
784 results